Women who gain and lose more than 10 pounds over and over again may face more than double the risk of kidney cancer compared to women whose weight stays steady.
Quick Take
- Women with 10 or more weight swings had over twice the risk of kidney cancer versus women with stable weight.
- Losing at least 10% of body weight after age 50 cut kidney cancer risk by 28%.
- Newer, larger studies find weaker or no link once researchers adjust for belly fat and overall body size.
- Weight loss after a cancer diagnosis is tied to worse outcomes, muddying the message for patients.
Repeated Weight Swings Linked to Kidney Cancer
A study in the American Journal of Epidemiology found women who changed their weight more than 10 times, gaining or losing over 10 pounds each time, had 2.6 times the risk of renal cell carcinoma (RCC), the most common form of kidney cancer, compared to women whose weight stayed stable. A separate prospective study on postmenopausal women found more than double the risk with heavy weight cycling.
Weight Loss Later in Life Shows Protection
Not all the news points to fear. A 2025 study following people over their lifetimes found that losing enough weight to cut body mass index (BMI) by 10% after age 50 was tied to a 28% drop in kidney cancer cases. Losing weight between ages 18 and 35 lowered risk by 21%. Every five-point rise in BMI raised risk for most kidney cancer types by 10% to 40%.
Obesity’s overall role is not in question. A broad review found each five-point BMI increase raised kidney cancer risk by 24% in men and 34% in women. Excess weight carried over decades, along with adult weight gain, showed the strongest ties to the clear cell type of kidney cancer, the most common subtype.
Not Every Study Agrees
The picture gets messier under closer inspection. When researchers behind the weight-cycling study adjusted for waist-to-hip ratio, a measure of belly fat, the link between weight swings and kidney cancer grew weaker. That suggests central body fat, not the up-and-down cycling itself, may be driving much of the risk.
A separate large study tracking more than 130,000 men and women found no link at all between weight cycling and kidney cancer once total body weight was accounted for. And an older case-control study of men found no meaningful risk from repeated weight-loss periods, with results too uncertain to draw firm conclusions. The effect also did not show up for two less common kidney cancer subtypes, papillary and chromophobe, suggesting the danger may be limited to the clear cell type.
Why the Confusion Matters for Patients
One finding complicates the whole story further. Weight loss that happens after someone is already diagnosed with kidney cancer is tied to higher death rates, not better outcomes. Researchers believe this is because aggressive tumors themselves cause weight loss, not the other way around. That makes it hard for doctors to tell patients whether shedding pounds is protective or a warning sign, depending on when it happens.
This split in the research reflects a wider pattern in cancer science, where studies on weight cycling and cancer risk have produced conflicting results for decades. Some studies report up to a threefold increase in risk for kidney and endometrial cancers, while others, including a major cohort of over 130,000 people, find no link once body weight is properly accounted for.
For everyday readers, the takeaway is not to panic over minor weight swings but to pay attention to long-term trends. Keeping weight stable, avoiding extreme yo-yo dieting, and losing excess weight gradually after midlife appear to carry the most consistent support across studies. Given how often researchers disagree even on basic numbers, patients deserve clear, honest guidance rather than one-size-fits-all warnings from health authorities eager to issue simple rules.
Doctors continue to stress that obesity, smoking, and high blood pressure remain the most solidly proven kidney cancer risk factors. Weight cycling appears to be a secondary, still-debated factor layered on top of those bigger drivers, not a replacement for them.
Sources:
docs.google.com, pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov, reuters.com, medscape.com
